Discover the full insider trade history of Griffin-American Healthcare REIT III, Inc., a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Real Estate sector, Griffin-American Healthcare REIT III, Inc. has recorded 16 reports. The latest transaction was reported on 4 October 2021 — Disposition. Among the most active insiders: Streiff Mathieu B.. The full history is accessible without an account.
0 of 0 declarations
Griffin-American Healthcare REIT III, Inc. is a U.S. healthcare real estate investment vehicle focused on owning and operating properties tied to the healthcare continuum. The company was incorporated in Maryland on January 11, 2013, and its SEC filings describe it as initially capitalized shortly thereafter. From inception, its strategy centered on a diversified portfolio of healthcare real estate, with primary emphasis on medical office buildings, hospitals, skilled nursing facilities, senior housing communities, and other healthcare-related assets. Early filings also list the company’s headquarters in Newport Beach, California, while later SEC documents place its business address in Irvine, California. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1566912/000156691220000075/gahr-20200930.htm?utm_source=openai)) For investors, the key analytical feature is that Griffin-American Healthcare REIT III operated as a specialized healthcare REIT rather than a broad diversified real estate platform. Its business model was built around acquiring income-producing properties leased to healthcare operators, and in some cases operating healthcare-related facilities under the RIDEA structure. That structure is important because it can allow a REIT to participate not only in rental income but also, where applicable, in a share of operating cash flow from certain senior housing or care facilities. This creates a mix of contractual real estate income and operating exposure that is more complex than a pure triple-net REIT, and it requires careful attention to tenant quality, occupancy, reimbursement dynamics, and capital intensity. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1566912/000156691215000137/hcr38-k100515exh991.htm?utm_source=openai)) In competitive terms, the company occupied a niche position in healthcare real estate, supported by the sponsorship of American Healthcare Investors and Griffin Capital. Those co-sponsors contributed sector expertise, sourcing capabilities, and capital-markets experience. The company’s reported portfolio focus was aligned with long-duration demand drivers such as aging demographics and the secular need for outpatient, post-acute, and senior housing infrastructure. Compared with large listed U.S. REITs on NYSE or NASDAQ, however, GAHR III was not a conventional exchange-listed equity. SEC materials identify the issuer with ticker “NONE,” which is consistent with a non-traded/private REIT profile rather than an actively quoted NYSE/NASDAQ listing. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1566912/000150453721000002/xslF345X03/wf-form4_163337900649086.xml?utm_source=openai)) The most important recent corporate event was the October 1, 2021 merger involving Griffin-American Healthcare REIT IV. SEC filings state that GAHR III merged into a wholly owned subsidiary of GAHR IV, and that the operating partnership was also merged into the surviving partnership. The transaction, together with the related acquisition of American Healthcare Investors’ platform, effectively consolidated the legacy Griffin-American healthcare REIT structure into what became American Healthcare REIT, Inc. As a result, Griffin-American Healthcare REIT III should now be viewed mainly as a legacy healthcare REIT platform whose historical portfolio, operating model, and sponsor relationships are material for understanding the successor company’s asset base and strategy. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1632970/000163297022000070/gahr-20220630.htm?utm_source=openai))